Literature DB >> 11319840

Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet beta-cells.

E L Saafi1, B Konarkowska, S Zhang, J Kistler, G J Cooper.   

Abstract

A view is emerging that human amylin (HA) kills pancreatic islet beta-cells by apoptosis. This study strengthens this view by documenting time-dependent morphological and ultrastructural changes in 10 microm HA-treated cultured RINm5F islet beta-cells. Membrane blebbing and microvilli loss were the earliest detectable apoptosis-related phenomena, already evident 1 h after HA exposure. Following 6-12 h of HA-treatment, chromatin margination became evident, consistent with detecting DNA laddering about the same time. Nuclear shrinkage, nuclear membrane convolution and prominent cytoplasmic vacuolization were clearly recognized at 22 h post-treatment. Together, these cellular changes constitute a strong case for HA-induced apoptosis, and further demonstrates that electron microscopy is a more sensitive tool for early apoptosis detection in cultured cells than classical biochemical assays like visualizing DNA laddering. The ultrastructural changes reported here contribute further evidence to be included in the ongoing dissection of molecular mechanisms underlying HA-induced apoptosis, as may occur in type-2 diabetes mellitus. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319840     DOI: 10.1006/cbir.2000.0643

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  25 in total

1.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane.

Authors:  Maarten F M Engel; Lucie Khemtémourian; Cécile C Kleijer; Hans J D Meeldijk; Jet Jacobs; Arie J Verkleij; Ben de Kruijff; J Antoinette Killian; Jo W M Höppener
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-11       Impact factor: 11.205

Review 2.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

3.  Is type 2 diabetes an amyloidosis and does it really matter (to patients)?

Authors:  G J S Cooper; J F Aitken; S Zhang
Journal:  Diabetologia       Date:  2010-03-13       Impact factor: 10.122

4.  Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3.

Authors:  E Law; S Lu; T J Kieffer; G L Warnock; Z Ao; M Woo; L Marzban
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

Review 5.  The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies.

Authors:  Andisheh Abedini; Julia Derk; Ann Marie Schmidt
Journal:  Protein Sci       Date:  2018-07       Impact factor: 6.725

Review 6.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

7.  Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress.

Authors:  R L Hull; S Zraika; J Udayasankar; K Aston-Mourney; S L Subramanian; S E Kahn
Journal:  Diabetologia       Date:  2009-04-08       Impact factor: 10.122

8.  Proteasome regulates turnover of toxic human amylin in pancreatic cells.

Authors:  Sanghamitra Singh; Saurabh Trikha; Anjali Sarkar; Aleksandar M Jeremic
Journal:  Biochem J       Date:  2016-06-23       Impact factor: 3.857

Review 9.  Mechanisms of islet amyloidosis toxicity in type 2 diabetes.

Authors:  Andisheh Abedini; Ann Marie Schmidt
Journal:  FEBS Lett       Date:  2013-01-18       Impact factor: 4.124

Review 10.  Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

Authors:  A Clark; M R Nilsson
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.